Related Experiment Video
Updated: Jul 26, 2025

07:23
Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
Published on: December 3, 2016
12.0K
Bizarre parosteal osteochondromatous proliferation: an educational review
Salvatore Gitto1,2, Francesca Serpi2, Carmelo Messina1,2
1IRCCS Istituto Ortopedico Galeazzi, via Cristina Belgioioso 173, 20157, Milan, Italy.
Insights Into Imaging
|June 19, 2023
Summary
Bizarre parosteal osteochondromatous proliferation (BPOP) is a benign bone tumor. This review details its imaging, pathology, and treatment, aiding diagnosis and patient care.
Area of Science:
- Orthopedic Oncology
- Radiology
- Pathology
Background:
- Bizarre parosteal osteochondromatous proliferation (BPOP) is a rare, surface-based benign chondrogenic bone tumor.
- It typically affects individuals in their third and fourth decades, with a predilection for the hands.
Purpose of the Study:
- To provide a comprehensive overview of BPOP, focusing on imaging characteristics.
- To discuss differential diagnoses, pathological findings, and treatment strategies for BPOP.
Main Methods:
- Review of existing literature on BPOP.
- Analysis of imaging features (radiography, CT, MRI).
- Correlation of imaging findings with histological characteristics and clinical presentation.
Main Results:
- BPOP presents as a well-defined, mineralized mass arising from the periosteal bone surface.
- Key imaging features include periosteal origin, lack of medullary involvement, and characteristic osteocartilaginous proliferation on histology.
- Differential diagnosis includes benign entities like florid reactive periostitis and malignant lesions such as periosteal chondrosarcoma.
Conclusions:
- Accurate multi-modality imaging is crucial for diagnosing BPOP.
- Understanding BPOP's features and differential diagnoses improves patient management.
- Surgical resection is the primary treatment, with awareness of potential local recurrences.
Related Concept Videos
Bone Formation by Endochondral Ossification
4.8K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
4.8K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Formation by Intramembranous Ossification
6.5K
Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
6.5K
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Growth of Cartilage and Bone Tissue
3.4K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.4K
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K

